" class="no-js "lang="en-US"> Stephen Powis Archives - Medtech Alert
Monday, June 17, 2024

Sort by:


Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Mobile Cataract Units and Same-day Hip Replacements Helping Thousands Get NHS Treatment

Same-day hip replacements, one stop shops and mobile cataract units are just some of the […]

New State-Of-The-Art NHS Hospital To Help Tackle Covid Backlog

A new ‘planned care’ hospital dedicated to non-emergency treatment is due to open in Berkshire […]

NHS Fast Tracks New ‘Gamechanging’ Drug for Lung Cancer

A targeted new drug for a rare and aggressive form of lung cancer will be […]

NHS Strikes Deal to Make PKU Drug Available For All

The NHS is set to make a drug for the rare, debilitating disorder phenylketonuria (PKU) […]

Total NHS Covid Vaccines Top 96 Million, Amid Concern Over New Variant

Total Covid vaccinations in England have hit the 96 million mark as the NHS Covid-19 […]

Top Up Jab Bookings to Open Up For More Than One Million People

More than one million people will be eligible to book their life-saving jab top-up from […]

UK Government Secures Groundbreaking COVID-19 Antivirals

Thousands of vulnerable patients could be taking ground-breaking COVID-19 antivirals this winter after the government […]

NHS Sets Out Next Stage of Covid Recovery Plan

Guidance to support hospitals with covid recovery over the next six months has been set […]

Innovation and New Technology to Help Reduce NHS Waiting Lists

Local surgical hubs, new technology to speed up diagnosis, and innovative ways of working will […]

Nationwide Roll-Out of NHS High Street Heart Checks to Save Thousands of Lives

Thousands of lives will be saved thanks to more blood pressure checks in high street […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more